Mojisola Adeyeye

Mojisola Christianah Adeyeye

Mojisola Christianah Adeyeye is a Nigerian pharmacist, pharmaceutical-science academic and public regulator. Reporting from July 2026 identified her as Director-General of Nigeria's National Agency for Food and Drug Administration and Control, which she was first appointed to lead in 2017 after an academic career in pharmaceutics and drug-product evaluation.

Star Mover ranking

Not ranked in News yet

0 points

No points are shown in this support ranking yet.

Sign in to Move Up

Profile

About Mojisola Adeyeye

Profile information current to 2026-08-22.

Nigeria · Pharmacist, Pharmaceutical-science academic, Public regulator · 1 affiliation

Show full profile Hide full profile

Also known as: Christianah Mojisola Adeyeye
Known for: Medicines and food regulation; Pharmaceutical sciences; Medical-products regulatory systems
Country: Nigeria

Pharmacist
Pharmaceutical-science academic
Public regulator

At a glance

Adeyeye was identified as NAFDAC's Director-General in July 2026 reporting.
Her work spans pharmacy, pharmaceutical science and the public regulation of medicines and food.
During her tenure, WHO announced in 2022 that Nigeria's medical-products regulator had reached maturity level 3 for medicines and imported-vaccine regulation.
Before leading NAFDAC, Adeyeye held senior academic positions in pharmaceutics and drug-product evaluation at universities in the United States.

Public regulatory leadership

Adeyeye's initial five-year appointment as NAFDAC Director-General took effect on 3 November 2017. Reporting later described a second five-year tenure as effective from 1 December 2022, while a separate February 2024 report said President Bola Tinubu had reappointed her amid changes in health-sector leadership. July 2026 reporting continued to identify her as Director-General, although the available evidence does not establish the precise legal structure or end date of her current tenure.

Education and academic career

A UNIDO-hosted biography states that Adeyeye earned a bachelor's degree from the University of Nigeria, Nsukka, followed by master's and doctoral degrees from the University of Georgia in Athens. It also identifies her as Professor Emeritus of Pharmaceutics and Drug Product Evaluation at Roosevelt University, founding chair of its Biopharmaceutical Sciences unit, and a former Professor of Pharmaceutics and Manufacturing at Duquesne University, where she worked for 21 years.

Regulatory-system development

Several institutional milestones occurred during Adeyeye's leadership of NAFDAC. WHO announced in March 2022 that Nigeria's regulator had attained maturity level 3 for medicines and imported-vaccine regulation, and WHO lists NAFDAC's Quality Control Laboratory in Yaba as prequalified from October 2023. An IMDRF document also records that NAFDAC became an affiliate member of the International Medical Device Regulators Forum in March 2024. These are institutional developments during her tenure rather than evidence of sole personal causation.

Drug-evaluation policy

Adeyeye signed a NAFDAC directive dated 29 November 2023 stating that bioequivalence data would become mandatory from January 2025 for specified drug-product dossier submissions. The directive reflects her role in the agency's regulation of pharmaceutical product evaluation and registration.

Affiliations

National Agency for Food and Drug Administration and Control Director-General present

Timeline

2017-11-03 Her initial five-year appointment as NAFDAC Director-General took effect.
2022-03-30 WHO announced that Nigeria's medical-products regulator had reached maturity level 3 for medicines and imported-vaccine regulation during Adeyeye's NAFDAC tenure.
2022-12-01 A NAFDAC public-affairs statement reported by TheCable said her second five-year NAFDAC tenure took effect.
2023-10-30 WHO lists NAFDAC's Quality Control Laboratory in Yaba, Nigeria, as prequalified.
2024-02-15 The Guardian Nigeria reported that President Bola Tinubu had reappointed Adeyeye as NAFDAC chief executive officer amid health-sector leadership changes.
2024-03-22 NAFDAC became an affiliate member of the International Medical Device Regulators Forum, according to an IMDRF document.

Additional verified details

Current context

Adeyeye was identified as Director-General of NAFDAC in July 2026 reporting. This is the most recent located direct title reference. Official NAFDAC materials located during research also identify her as Director-General, but the latest such document located was dated 2023.

Biographical facts

A UNIDO biographical document states that Adeyeye earned a bachelor's degree from the University of Nigeria, Nsukka, and master's and doctoral degrees from the University of Georgia in Athens.
A UNIDO biographical document identifies Adeyeye as Professor Emeritus of Pharmaceutics and Drug Product Evaluation at Roosevelt University, founding chair of its Biopharmaceutical Sciences unit, and a former Professor of Pharmaceutics and Manufacturing at Duquesne University for 21 years.
An official NAFDAC directive signed by Adeyeye and dated 29 November 2023 stated that bioequivalence data would become mandatory from January 2025 for specified drug-product dossier submissions.